EUVIMEDEUVIMED entdecken
Vergleichsstudie

Prospective comparative trial comparing O‐RADS , IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer

Vitcha Poonyakanok iD, Prasong Tanmahasamut iD, Atthapon Jaishuen iD

Journal of Obstetrics and Gynaecology Research · 2023-05 · 49 (5) · 1412-1417

DOI: 10.1111/jog.15624 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 09.03.2023. Verfasst von Vitcha Poonyakanok und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Adnexal Diseases, Ovarian Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Preoperative assessment of ovarian tumors to distinguish between benign and malignant is important. At this time, many diagnostic models were available and the popularity of the risk of malignancy index (RMI) in Thailand is still high. The IOTA Assessment of Different NEoplasias in adneXa (ADNEX) model and the Ovarian‐Adnexal Reporting and Data System (O‐RADS) model were both new models with good performance.

Objectives

The purpose of this study was to compare O‐RADS, RMI, and ADNEX models.

Design

This diagnostic study was performed using data from the prospective study.

Methods

Data from 357 patients from a previous study were included and calculated using the RMI‐2 formula then applied to the O‐RADS system and the IOTA ADNEX model. The diagnostic significance of the results was evaluated by receiver operating characteristic (ROC) analysis and pairwise comparison between models was made.

Results

The area under the receiver operating characteristic curve (AUC) to distinguish an adnexal mass as a benign or malignant tumor was 0.975 (95% CI, 0.953–0.988) for the IOTA ADNEX model; 0.974 (95% CI, 0.960–0.988) for O‐RADS; 0.909 for RMI‐2 (95% CI, 0.865–0.952). There were no differences in pairwise AUC comparisons between the IOTA ADNEX and O‐RADS models, and both were better than those of RMI‐2.

Conclusions

The IOTA ADEX and O‐RADS models are excellent tools for distinguishing the adnexal mass in the preoperative assessment and were better than RMI‐2. The use of one of these models is recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adnexal DiseasesOvarian NeoplasmsFemaleHumansProspective StudiesRisk FactorsSensitivity and SpecificityUltrasonography

Stichwörter der Autor:innen

benign disease of ovary and fallopian tubesepithelial cancer of the ovarygynecologic imaging

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Vitcha Poonyakanok, Prasong Tanmahasamut, Atthapon Jaishuen

Zitieren

APA

Poonyakanok, V., Tanmahasamut, P., & Jaishuen, A. (2023). Prospective comparative trial comparing O‐RADS , IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer. Journal of Obstetrics and Gynaecology Research, 49(5), 1412-1417. https://doi.org/10.1111/jog.15624

Vancouver

Poonyakanok V, Tanmahasamut P, Jaishuen A. Prospective comparative trial comparing O‐RADS , IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer. Journal of Obstetrics and Gynaecology Research. 2023;49(5):1412-1417. doi:10.1111/jog.15624

BibTeX
@article{Poonyakanok2023,
  author = {Poonyakanok, Vitcha and Tanmahasamut, Prasong and Jaishuen, Atthapon},
  title = {Prospective comparative trial comparing O‐RADS , IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2023},
  volume = {49},
  number = {5},
  pages = {1412--1417},
  doi = {10.1111/jog.15624}
}
Kostenlos starten →